GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
7VD5 | A0A679C012 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679C209 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679BVT0 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | B7XBY7 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679BVT8 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679C298 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679BWI3 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679C262 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679C2A0 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | B6ZHE8 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | B6ZHE9 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679C6E6 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | B6ZHF0 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | B6ZHF4 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679C6E8 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | B6ZHF2 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679BVT2 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VD5 | A0A679C215 | Structure of C2S2M2-type PSII-FCPII supercomplex from diatom | |
7VCP | A0A0A7S0J1 | Frischella perrara beta-fructofuranosidase in complex with fructose | |
7VC7 | 7VC7 | The structure of beta-xylosidase from Phanerochaete chrysosporium(PcBxl3) | |
7VC6 | 7VC6 | The structure of beta-xylosidase from Phanerochaete chrysosporium(PcBxl3) | |
7VAZ | 7VAZ | Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS) | |
7VAZ | P15941 | Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS) | |
7VAC | 7VAC | Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST) | |
7VAC | P15941 | Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST) | |
7V8Q | 7V8Q | Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT) | |
7V8Q | P15941 | Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT) | |
7V8C | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation | |
7V8B | P0DTC2 | Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V8B | Q9BYF1 | Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V8B | 7V8B | Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V8B | Q9BYF1 | Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V8B | 7V8B | Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V8A | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V8A | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V8A | 7V8A | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V8A | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V8A | 7V8A | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V89 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
7V89 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
7V89 | 7V89 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
7V89 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
7V89 | 7V89 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
7V88 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V88 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V88 | 7V88 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V88 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V88 | 7V88 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V87 | P0DTC2 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V87 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024